The review, which was spurred by controversy over the FDA's Aduhelm approval, recommends two main changes in agency ...

The FDA has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs with a new active substance in ...

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...

Canada lags behind other developed countries when it comes to the length of time it takes to approve desperately needed ...

Kyung Bo Kim discovered compounds that improved cognitive function regardless of amyloid plaque buildup — an encouraging sign ...

With each new year comes a new set of accompanying challenges, from tackling the latest innovations to new incarnations of old issues. 2025 will be ...

to the most approved drugs with a new active substance in 2024. On 15 January, the two agencies released respective lists of medicines approved last year. The FDA approved 50 novel drugs that ...

Three new drugs have been approved to treat anaemic patients suffering from Paroxysmal nocturnal haemoglobinuria, estimated to impact 1.59 people per 100,000 in the UK, with 38 patients treated in ...